Z-0505-2018 Class II Terminated

Recalled by Cardiovascular Systems Inc — Saint Paul, MN

FDA device recall Z-0505-2018 was initiated by Cardiovascular Systems Inc on Sep 14, 2017 and is designated Class II. Reason for recall: Cardiovascular Systems, Inc. (CSI) is removing the products because it was identified that the labeling for two lots of product s were potentially inadvertently switched during production. The recall status is terminated (terminated Nov 4, 2019). Affected quantity: 8.

Recall Details

Product Type
Devices
Report Date
Feb 14, 2018
Initiation Date
Sep 14, 2017
Termination Date
Nov 4, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8

Product Description

Peripheral Diamondback 1.25 Solid OAD, a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy.

Reason for Recall

Cardiovascular Systems, Inc. (CSI) is removing the products because it was identified that the labeling for two lots of product s were potentially inadvertently switched during production.

Distribution Pattern

FL, IL, MI, MN, MO, NY, SC, TX, and WI

Code Information

Lot # 190097 Part #: 7-10012 Model # DBP-125SOLID145

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0505-2018
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.